UK knighthood for NICE chief executive Dillon
This article was originally published in RAJ Devices
Andrew Dillon, chief executive of the UK's National Institute for Health and Clinical Excellence, has been awarded a knighthood for services to healthcare in the New Year's Honours list.
You may also be interested in...
Japanese company Daiichi Sankyo has its eye on first-line FLT3-ITD AML indication after rejection of relapsed/refractory plans in EU and US.
Rigel Pharmaceuticals and Jazz Pharmaceuticals are among the companies that could find out this week whether their new drug applications at the European Medicines Agency are likely to be approved for marketing across the EU. The EMA's key scientific committee, the CHMP, will also consider applications from Roche and Novartis.